Transmedics Group Inc

NASDAQ:TMDX  
31.69
-0.54 (-1.68%)
Products

Transmedics Receives FDA Approval For Its OCS Heart System Enabling Broader Utilization Of Donor Hearts For Transplantation In The U.S.­

Published: 09/07/2021 11:23 GMT
Transmedics Group Inc (TMDX) - Transmedics Receives FDA Approval for Its Ocs Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.­.